EEG-Mapped TMS (E-MapT) in Austin, TX

TMS Informed by Your Brain's EEG Data

E-MapT is Neurolimits' EEG-Mapped TMS approach: an individualized method that combines resting-state EEG brain mapping with clinical assessment to help inform how transcranial magnetic stimulation is planned. Instead of relying only on a standard anatomical target, the team reviews objective brain-activity data alongside your symptoms, history, and treatment goals.

The EEG does not diagnose a condition or guarantee a treatment response. It provides an additional source of information. When the clinical team determines that an EEG-informed approach is appropriate, those findings can help guide the selection of TMS targets and protocols while treatment response is tracked over time.

EEG-informed treatment planning • Non-invasive TMS • Objective brain data • Austin, Texas

(512) 588-1182

Quick Facts About EEG-Mapped TMS

  • E-MapT stands for EEG-Mapped TMS
  • Begins with a resting-state EEG recording to characterize the individual's brain activity
  • EEG findings are reviewed alongside symptoms, history, goals, and clinical assessment
  • The EEG is used to inform TMS target selection and protocol planning rather than applying the same approach to every person
  • TMS remains non-invasive: magnetic pulses are delivered through a coil positioned against the scalp
  • EEG sensors only record electrical activity; they do not deliver electricity into the brain
  • E-MapT is part of Neurolimits' individualized neuroscience program in Austin
  • The approach can be integrated with standard TMS, neurofeedback, psychotherapy, and other clinically appropriate services

How It Works

What Is EEG-Mapped TMS?

What EEG-Mapped TMS Means

E-MapT is Neurolimits' EEG-informed approach to transcranial magnetic stimulation. Standard TMS protocols commonly use validated anatomical targets and established stimulation parameters for a specific indication. E-MapT adds another layer of information: a resting-state EEG recording is reviewed before treatment planning so the team can examine how electrical activity is distributed across the brain and how that pattern relates to the individual's symptoms, history, and goals. The EEG does not diagnose a psychiatric or neurological condition by itself, and it does not replace a clinical evaluation. Its role is to provide additional objective information that may help the team decide which brain networks deserve closer attention when designing an individualized stimulation plan.

Why Add EEG Information to TMS Planning?

Two people can have the same diagnosis and still show very different symptom profiles, cognitive strengths, network patterns, medication histories, and responses to prior treatment. E-MapT is designed around that variability. Instead of assuming that every person with the same label should receive an identical stimulation strategy, the team reviews the EEG together with clinical information and determines whether an individualized target or protocol is appropriate. The practical goal is precision: use the best available information about the individual before selecting where, how, and why stimulation is delivered. This does not mean the EEG can predict with certainty whether TMS will work, and Neurolimits does not present E-MapT as a guaranteed or diagnostic test.

How the EEG and TMS Parts Fit Together

The EEG and TMS portions are separate steps. First, scalp electrodes record the brain's naturally occurring electrical activity while the person rests quietly. The data are processed and reviewed for features that may be clinically relevant. Second, the clinical team integrates those findings with symptoms, history, prior treatment response, and the reason TMS is being considered. Third, a TMS plan is selected. During TMS itself, a magnetic coil is positioned against the scalp and delivers repeated magnetic pulses to the selected cortical target. The EEG is therefore a mapping and planning tool; it is not the stimulation. TMS is the stimulation component. Keeping those roles separate is important because clients often assume that EEG sensors are putting electricity into the brain. They are not.

E-MapT vs. Standard TMS

Standard TMS uses evidence-based protocols with predefined target locations and stimulation parameters. Those protocols remain important and may be the right choice for many people. E-MapT is intended for situations in which the clinical team believes that additional individualized information could be useful for treatment planning. The decision to use a standard protocol, an EEG-informed protocol, or another approach should be made clinically rather than automatically. Neurolimits also tracks symptoms and clinical response throughout treatment. EEG information can contribute to the baseline picture, but treatment decisions should continue to consider how the person is actually responding.

Who May Be a Candidate for E-MapT?

  • People considering TMS who want an individualized treatment-planning process rather than a purely one-size-fits-all approach
  • Clients whose symptoms or prior treatment history suggest that a broader network-level assessment may be useful
  • People who already have resting-state EEG data collected at Neurolimits and may benefit from integrating those findings into TMS planning
  • Clients receiving TMS as part of a broader plan that may also include neurofeedback, psychotherapy, psychiatric care, sleep evaluation, or other services
  • People interested in objective baseline brain data that can be reviewed together with symptom and clinical measures
  • Selected clients receiving off-label TMS protocols when the treating team determines that individualized targeting is clinically appropriate

What a Resting EEG Can and Cannot Tell Us

A resting-state EEG measures electrical activity recorded from the scalp. It can show features such as the relative distribution of frequency activity, regional differences, and patterns of functional organization that can be compared with other information about the individual. At Neurolimits, EEG data are used as one piece of the clinical picture.

An EEG does not independently establish that someone has depression, ADHD, anxiety, autism, or another psychiatric diagnosis. It also cannot guarantee that a person will respond to TMS. Those distinctions matter. The value of EEG in E-MapT is that it provides objective physiological data that can be considered alongside symptoms and clinical history when planning stimulation.

For a separate explanation of how Neurolimits records and interprets brain activity, see QEEG brain mapping in Austin. For the standard treatment overview, see TMS in Austin.

EEG-Mapped TMS and Neurofeedback Are Different Tools

Both services can involve EEG data, but they work in different ways. Neurofeedback measures brain activity during training and provides real-time visual or auditory feedback so the brain can learn to regulate its own activity patterns. TMS uses a magnetic coil to directly influence activity in targeted cortical tissue.

In E-MapT, the EEG is primarily used to inform assessment and stimulation planning. In neurofeedback, EEG is part of the training loop itself. Some clients may receive one service; others may receive both as part of a coordinated plan when clinically appropriate. Learn more about Neurofeedback in Austin and TMS in Austin.

The Process

What to Expect From EEG-Mapped TMS at Neurolimits

Step 1: Clinical Consultation

The process starts with the clinical question, not the EEG. We review symptoms, diagnoses, medical and psychiatric history, medications, prior treatments, goals, and factors that may affect whether TMS is appropriate or safe.

Step 2: Resting-State EEG Recording

EEG sensors are placed on the scalp to record naturally occurring electrical activity while you rest quietly. The recording is non-invasive. The sensors measure activity; they do not stimulate the brain or send electricity into the scalp.

Step 3: EEG Analysis and Brain-Pattern Review

The EEG is processed and reviewed for patterns that may be relevant to the treatment question. The team interprets these data in context rather than treating an EEG feature as a diagnosis by itself.

Step 4: TMS Target and Protocol Planning

The clinical and neuroscience teams combine the EEG findings with the clinical assessment to decide whether an EEG-informed target or protocol is appropriate. The plan specifies the intended cortical target, stimulation approach, intensity framework, and treatment schedule.

Step 5: TMS Treatment

During treatment, a magnetic coil is positioned against the scalp over the selected target. Repeated magnetic pulses stimulate the underlying cortical tissue. You remain awake, no anesthesia is required, and most people return to normal activities after the session.

Step 6: Progress Tracking and Refinement

Symptoms, tolerability, and functional changes are tracked during the course. The clinical team reviews progress and determines whether any clinically appropriate adjustments are needed. When useful, follow-up EEG data may provide an additional objective comparison with baseline.

Questions

Frequently Asked Questions

E-MapT stands for EEG-Mapped TMS. At Neurolimits, the term refers to using resting-state EEG information together with clinical assessment to inform an individualized transcranial magnetic stimulation plan.

No. E-MapT at Neurolimits is EEG-Mapped TMS and is not EMDR or an eye-movement trauma-processing treatment. It combines EEG-based brain information with TMS treatment planning.

No. EEG electrodes record electrical activity from the scalp. They do not deliver electrical stimulation. The stimulation portion of E-MapT comes from the TMS coil, which uses magnetic pulses.

No. EEG findings can provide objective information about brain activity, but they should not be used by themselves to diagnose psychiatric or neurological conditions. Diagnosis depends on the full clinical evaluation.

Standard TMS generally uses established targets and protocols for a specific clinical indication. EEG-Mapped TMS adds individualized EEG information to the planning process when the clinical team believes that information may be useful.

Not necessarily. Some people are best served by a standard evidence-based TMS protocol. The clinical team determines whether an EEG-informed approach is appropriate based on the treatment question and the individual's history.

Yes, when clinically appropriate. Neurofeedback and TMS are different interventions, and a coordinated plan may use one or both depending on the client's goals and clinical needs.

E-MapT is provided through Neurolimits in Austin, Texas. EEG recording, clinical review, treatment planning, and TMS sessions are coordinated through the Neurolimits team.

Clinical content prepared by the Neurolimits clinical and neuroscience team.

Reviewed for clinical accuracy by Jorge Chavez, PhD, Clinical Psychologist and Clinical Director on January 12, 2026.

Want to Know Whether EEG-Mapped TMS Fits Your Goals?

Start with a clinical conversation. We can explain how E-MapT differs from standard TMS, what the EEG contributes, and whether an individualized EEG-informed approach makes sense for your situation.

Book a Consultation

GET STARTED

Go Beyond What You Thought Possible